MMP7 -181G allele Is a low-penetrant risk factor for cancer development in East Asians

DNA and Cell Biology

Volumn 31, Issue 5, 2012, Pages 772-776

  Yuan Yuan, Mi ^a   Li Feng, Zhang ^b   Li Jie, Zhu ^a  

^a NANTONG UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MATRILYSIN;

ALLELE; ARTICLE; ASIAN; CANCER GROWTH; CANCER RISK; GENE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HUMAN; META ANALYSIS (TOPIC); MMP7 GENE; PENETRANCE; PRIORITY JOURNAL; PUBLISHING; RISK FACTOR; SENSITIVITY ANALYSIS;

CASE-CONTROL STUDIES; FAR EAST; GENOTYPE; HUMANS; MATRIX METALLOPROTEINASE 7; META-ANALYSIS AS TOPIC; NEOPLASMS; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS;

EID: 84861388646     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1416     Document Type: Article

References (35)

1. Chakraborti, S., Mandal, M., Das, S., Mandal, A., and Chakraborti, T. (2003). Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253, 269-285.
2. DerSimonian, R., and Laird, N. (1986). Meta-analysis in clinical trials. Control Clin Trials 7, 177-188. (Pubitemid 17189972)
3. Egeblad, M., and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2, 161-174. (Pubitemid 37328786)
4. Egger, M., Davey Smith, G., Schneider, M., and Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634. (Pubitemid 27387172)
5. Fang, W.L., Liang, W.B., He, H., Zhu, Y., Li, S.L., Gao, L.B., and Zhang, L. (2010). Association of matrix metalloproteinases 1, 7, and 9 gene polymorphisms with genetic susceptibility to colorectal carcinoma in a Han Chinese population. DNA Cell Biol 29, 657-661.
6. Forget, M.A., Desrosiers, R.R., and Béliveau, R. (1999). Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis. Can J Physiol Pharmacol 77, 465-480. (Pubitemid 29500892)
7. Higgins, J.P., Thompson, S.G., Deeks, J.J., andAltman, D.G. (2003).Measuring inconsistency in meta-analyses. BMJ 327, 557-560. (Pubitemid 37088507)
8. Hojilla, C.V., Mohammed, F.F., and Khokha, R. (2003). Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 89, 1817-1821. (Pubitemid 37533251)
9. Hulboy, D.L., Gautam, S., Fingleton, B., and Matrisian, L.M. (2004). The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse. Oncol Rep 12, 13-17.
10. Ii, M., Yamamoto, H., Adachi, Y., Maruyama, Y., and Shinomura, Y. (2006). Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 231, 20-2.
11. Jormsjö , S., Whatling, C., Walter, D.H., Zeiher, A.M., Hamsten, A., and Eriksson, P. (2001). Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 21, 1834-1839. (Pubitemid 34219789)
12. Kitoh, T., Yanai, H., Saitoh, Y., Nakamura, Y., Matsubara, Y., Kitoh, H., Yoshida, T., and Okita, K. (2004). Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer. J Gastroenterol 39, 434-440. (Pubitemid 38811726)
13. Kubben, F.J., Sier, C.F., Meijer, M.J., van den Berg, M., van der Reijden, J.J., Griffioen, G., van de Velde, C.J., Lamers, C.B., and Verspaget, H.W. (2006). Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer 95, 744-751. (Pubitemid 44373491)
14. Li, Y., Jin, X., Kang, S., Wang, Y., Du, H., Zhang, J., Guo, W., Wang, N., and Fang, S. (2006). Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol 101, 92-96.
15. Lu, Z., Wang, Y., Zhang, Q., Zhang, X., Wang, S., Xie, H., Li, Y., Jiao, B., and Zhang, J. (2006). Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma. Brain Res 1118, 6-12. (Pubitemid 44633856)
16. Lu, Z.Q., Wang, Y.M., Cao, Y.Y., Zhang, Q.J., Zhang, X.H., Li, Y.H., Wang, H.S., Xie, H.L., Jiao, B.H., and Zhang, J.H. (2007).Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma. Ai Zheng 26, 463-468.
17. Malemud, C.J. (2006). Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11, 1696-1701. (Pubitemid 43253387)
18. Malik, M.A., Zargar, S.A., and Mittal, B. (2011). Role of the metalloproteinase-7 (181A > G) polymorphism in gastric cancer susceptibility: a case control study in Kashmir Valley. Asian Pac J Cancer Prev 12, 73-76.
19. Mantel, N., and Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-748.
20. Matsumura, S., Oue, N., Nakayama, H., Kitadai, Y., Yoshida, K., Yamaguchi, Y., Imai, K., Nakachi, K., Matsusaki, K., Chayama, K., and Yasui, W. (2005). A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 131, 19-25.
21. Miyata, Y., Iwata, T., Ohba, K., Kanda, S., Nishikido, M., and Kanetake, H. (2006). Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma:prognostic implications and clinical significance for invasion and metastasis. Clin Cancer Res 12, 6998-7003. (Pubitemid 44974495)
22. Qiu, W., Zhou, G., Zhai, Y., Zhang, X., Xie, W., Zhang, H., Yang, H., Zhi, L., Yuan, X., Zhang, X., and He, F. (2008). No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population. Cancer Epidemiol Biomarkers Prev 17, 2514-2518.
23. Singh, H., Jain, M., and Mittal, B. (2008). MMP-7 (-181A > G) promoter polymorphisms and risk for cervical cancer. Gynecol O1. ncol 110, 71-75.
24. Srivastava, P., Gangwar, R., Kapoor, R., and Mittal, R.D. (2010).Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population. Dis Markers 29, 37-46.
25. Sugimoto, M., Furuta, T., Kodaira, C., Nishino, M., Yamade, M., Ikuma, M., Sugimura, H., and Hishida, A. (2008). Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan. J Gastroenterol 43, 751-761.
26. Sugimoto, M., Yoshida, S., Kennedy, S., Deguchi, M., Ohara, N., and Maruo, T. (2006). Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population. J Soc Gynecol Investig 13, 523-529. (Pubitemid 44528299)
27. Tanioka, Y., Yoshida, T., Yagawa, T., Saiki, Y., Takeo, S., Harada, T., Okazawa, T., Yanai, H., and Okita, K. (2003). Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 89, 2116-2121. (Pubitemid 38030912)
28. Vairaktaris, E., Serefoglou, Z., Yapijakis, C., Vylliotis, A., Nkenke, E., Derka, S., Vassiliou, S., Avgoustidis, D., Neukam, F.W., and Patsouris, E. (2007). High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer. Anticancer Res 27, 2493-2498. (Pubitemid 47228094)
29. VanSaun, M.N., and Matrisian, L.M. (2006). Matrix metalloproteinases and cellular motility in development and disease. Birth Defects Res C Embryo Today 78, 69-79. (Pubitemid 43726176)
30. Wang, W.S., Chen, P.M., Wang, H.S., Liang, W.Y., and Su, Y. (2006). Matrix metalloproteinase-7 increases resistance to Fasmediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis 27, 1113-1120.
31. Wilson, C.L., and Matrisian, L.M. (1996). Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28, 123-136. (Pubitemid 26072499)
32. Woo, M., Park, K., Nam, J., and Kim, J.C. (2007). Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 22, 1064-1070. (Pubitemid 47019841)
33. Wu, S., Lu, S., Tao, H., Zhang, L., Lin, W., Shang, H., and Xie, J. (2011). Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer. J Huazhong Univ Sci Technolog Med Sci 31, 114-119.
34. Yi, Y.C., Chou, P.T., Chen, L.Y., Kuo, W.H., Ho, E.S., Han, C.P., and Yang, S.F. (2010). Matrix metalloproteinase-7 (MMP-7) p1. olymorphism is a risk factor for endometrial cancer susceptibility. Clin Chem Lab Med 48, 337-344.
35. Zhang, J., Jin, X., Fang, S., Wang, R., Li, Y., Wang, N., Guo, W., Wang, Y., Wen, D., Wei, L., Dong, Z., and Kuang, G. (2005).The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 26, 1748-1753. (Pubitemid 41487990)